ArticlePsychiatry and clinical psychopharmacology2025
Serum Cytokines as Biomarkers for Comorbid Anxiety in Postpartum Depression: A Machine Learning Approach.
Article in Psychiatry and clinical psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epidemiology, pathophysiology, and interventions for postpartum depression: Systematic review.World journal of clinical cases · 2025Article
- Personality, Perinatal Anxiety, and Substance Use as Converging Determinants of Post-Partum Depression in South-East Europe.Medicina (Kaunas, Lithuania) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to investigate the serum levels of interleukin 2, interleukin 6 (IL-6), interleukin 10, and tumor necrosis factor-alpha in patients with postpartum depression (PPD) and to explore their potential as biomarkers for PPD and comorbid anxiety using machine learning techniques. Methods: Serum samples were collected from 53 patients diagnosed with PPD and 35 healthy controls. Cytokine levels were measured using a flow cytometer analyzer. Machine learning models, including Multinomial Logistic Regression, Decision Trees, Random Forest, and Support Vector Machines (SVMs), were developed to predict PPD and comorbid anxiety based on cytokine levels. Results: Patients with PPD exhibited significantly elevated serum levels of IL-6 compared to the control group. A positive correlation was found between psychological anxiety scores and IL-6 levels (r = 0.483, P < .001). Machine learning models, particularly the Random Forest and SVMs, demonstrated high accuracy in predicting PPD and comorbid anxiety, with IL-6 being identified as a key predictor. Conclusion: The activation of serum cytokines is evident in PPD patients, with IL-6 potentially serving as an auxiliary biomarker for the diagnosis of PPD and comorbid anxiety. The incorporation of machine learning techniques has enhanced the understanding of the complex relationships between cytokines and PPD, with IL-6 levels showing a correlation to the severity of clinical symptoms.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.